Augment Approval Provides Catalyst for Wright Medical (WMGI), Brean Capital Says
Tweet Send to a Friend
Brean Capital analyst Jason Wittes reiterated a Buy rating and $38 price target on Wright Medical (NASDAQ: WMGI), saying Augment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


